Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$7.4K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 4 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 11 business days late.
The 11 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| BTAI |
| BioXcel Therapeutics, Inc. |
| SSELL◷ |
| 6,845 |
| $1.09 |
| $7.4K |
| -20.7% |
| Open the original filing on SEC.gov |
| May 4 | BTAI | BioXcel Therapeutics, Inc. | MEXER◷◆ | 17,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | BTAI | BioXcel Therapeutics, Inc. | MEXER◷ | 17,500 | — | — | +112.8% | Open the original filing on SEC.gov |
| May 1 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 9,000 | — | — | — | Open the original filing on SEC.gov |
| May 1 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 9,000 | — | — | +138.0% | Open the original filing on SEC.gov |
| Mar 15 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 35 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 35 | — | — | +0.5% | Open the original filing on SEC.gov |
| Mar 14 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 33 | — | — | — | Open the original filing on SEC.gov |
| Mar 14 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 33 | — | — | +0.5% | Open the original filing on SEC.gov |